Namita Thapar Biography: Everything about Executive Director of Emcure Pharmaceutical who is Investor at Shark Tank India

17 Jan, 2023
Namita Thapar Biography: Everything about  Executive Director of Emcure Pharmaceutical who is Investor at Shark Tank India

Namita Thapar Biography

Name- Namita Thapar

date of Birth- 21st March 1997

Relationship status- Married to Vikas Thapar

Profession-  Executive Director of Emcure Pharmaceuticals

In News- Shark Tank India 2 judge

 

Who is Namita Thapar?

One of the leading business ladies of India, Namita Thapar is  the Executive Director of Emcure Pharmaceuticals. Emcure Pharmaceuticals is an Indian multinational pharmaceutical company headquartered in Pune, Maharashtra. While she is a known face in the business world, she came into the eyes of the general public as an investor in Shark Tank India.

 

 
 
 
View this post on Instagram

A post shared by Namita Thapar (@namitathapar)

 

Who is Namita Thapar?

Born on 21 March 1977, Namita Thapar hails from Pune Maharashtra. She is Married to Vikas Thapar and have two sons named Vir Thapar and Jai Thapur. She did her schooling from a school in Pune, Maharashtra and later completed her chartered accountant degree from ICAI. Later Namita went to do MBA and did her degree from Fuqua School of Business at Duke University. 

 
 
 
View this post on Instagram

A post shared by Namita Thapar (@namitathapar)


Namita Thapar Career

After working for 6 years at Guidant Corporation, USA, Namita joined Emcure as CFO. Later her work area expanded in Indian Business as well and today she is serving as the Executive Director of Emcure Pharmaceuticals. 


  • Namita is also serving as a Board Member on the India Regional Advisory Board of Fuqua School of Business. 

  • Serving as a trustee on TiE Mumbai Board of Trustees. 

  • And is also an active member of the Young Presidents Organization. 


Apart from work she is also  a speaker at various prestigious forums such as Harvard Business School, Indian Institute of Management (IIM- A), ET women’s conference, FICCI etc.


What is Emcure Pharmaceuticals?

‘Emcure Pharmaceuticals is an Indian multinational pharmaceutical company headquartered in Pune, Maharashtra. Emcure's product portfolio includes tablets, capsules and injectables.’ The Company has its work expanded globally while it is headquartered in Pune, Maharashtra. It has a  turnover of 6000 crores ($750 million). It has a presence in 70 countries and an employee strength of over 10,000.

Awards and Recognition to Namita Thapar

  • The Economic Times ‘40 under Forty’ award.

  • Barclays Hurun Next Gen Leader recognition.

  • Economic Times 2017 Women Ahead List.

  • World Women Leadership Congress Super Achiever award.


Namita Thapar working with Govt. of India

Apart from the business, Namita is also connected with various government initiatives such as 'Women Entrepreneurship Platform' and 'Digital Health Task Force' by NITI Aayog and ‘Champions of Change’. These programs are  initiated by PM Narendra Modi for G2B partnership in policy making.

Namita Thapar Active Investor

Namita Tahpar is always driven towards  youth entrepreneurship and founded Incredible Ventures Ltd. It's an education company that teaches entrepreneurship to 11 -18 year olds in Mumbai, Delhi, Bangalore, Pune, Chennai and Ahmedabad.

She herself is an active investor and follows news business ideas. 

Namita Thapar Shark Tank

While Namita is a known face in the business community and is aceing as a woman entrepreneur, she is becoming a household face as a judge in Shark Tank India. Shark Tank India is an Indian adaptation of a popular American business reality show which judges and evaluates new business models and ideas and later the judges also known as Sharks invest in them. 

 

 
 
 
View this post on Instagram

A post shared by Shark Tank India (@sharktank.india)

Related videos

यह भी पढ़ें

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy.Accept
BACK